Long-Term Omalizumab use in the Treatment of Exercise-Induced Anaphylaxis
Reported is a case of a 39-year-old male who was diagnosed with exercise-induced anaphylaxis (EIA). He was initially treated prophylactically with fexofenadine, montelukast, and ranitidine. He also used an epinephrine autoinjector as needed. He was refractory to these medications and continued to ha...
Main Authors: | Mark R. Peterson D.O., Christopher A. Coop M.D. |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-10-01
|
Series: | Allergy & Rhinology |
Online Access: | https://doi.org/10.2500/ar.2017.8.0204 |
Similar Items
-
Novel Treatment of Allergic Fungal Sinusitis Using Omalizumab
by: Martin Oman Evans D.O., et al.
Published: (2014-09-01) -
A case report of food-dependent exercise-induced anaphylaxis (FDEIA) treated with omalizumab
by: Sara Mohamed, et al.
Published: (2024-10-01) -
Omalizumab: Practical considerations regarding the risk of anaphylaxis
by: Kim Harold L, et al.
Published: (2010-12-01) -
Severe exercise-induced anaphylaxis in a hot and humid area successfully treated with omalizumab: a case report
by: Hassan Mobayed, et al.
Published: (2023-07-01) -
Steroid Sparing Effect of Omalizumab in Seropositive Allergic Bronchopulmonary Aspergillosis
by: Keith T. Beam M.D., et al.
Published: (2015-06-01)